A multicenter, randomized, double-blind, parallel group,

Project: Research project

Project Details

Description

A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction
StatusFinished
Effective start/end date5/1/143/1/20

Funding

  • Novartis Pharma AG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.